Pluristem Therapeutics, Inc. News Headlines

PSTI 
$3.64
*  
unch
 negative 
unch
Get PSTI Alerts
*Delayed - data as of Apr. 24, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PSTI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Israeli Biomed-Tech Companies Present Investment Opportunities
4/9/2014 9:10:00 AM - Seeking Alpha

Pluristem's Plant Approval From The FDA Could Provide Pathway To New Drug Partners
3/12/2014 2:26:00 PM - Seeking Alpha

Osiris Therapeutics: Poised For Another Breakout
3/11/2014 2:07:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade
3/6/2014 9:46:54 AM - MT Newswires

Sector Update: Healthcare
3/6/2014 9:45:13 AM - MT Newswires

Pluristem Therapeutics Says FDA Oks Commercial Scale Cell Manufacturing Process
3/6/2014 4:19:00 AM - RTT News

Pluristem's Preeclampsia Effort Pushes PLX Platform
2/26/2014 10:29:00 AM - Seeking Alpha

Pipeline Progress at Pluristem - Analyst Blog
2/24/2014 6:50:01 PM - Zacks.com

BMRN Awaits EMA Nod, KIN Hits A High, Nuvilex Gets Rich, OHRP A Sight Better
2/20/2014 10:38:00 PM - RTT News

Will Regeneron (REGN) Disappoint in Q4? - Analyst Blog
2/10/2014 5:30:01 PM - Zacks.com

Company news for February 05, 2014 - Corporate Summary
2/5/2014 11:06:01 AM - Zacks.com

Study on Pluristem's Placental Cells - Analyst Blog
2/4/2014 6:40:01 PM - Zacks.com

Manufacturing Approval for Pluristem Facility - Analyst Blog
1/28/2014 6:50:01 PM - Zacks.com

Earnings Estimates Moving Higher for Pluristem Therapeutics (PSTI): Time to Buy? - Tale of the Tape
1/27/2014 9:36:01 AM - Zacks.com

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
1/22/2014 2:00:00 PM - Seeking Alpha

Mesoblast Is No Match For Pluristem's IP And Manufacturing
1/16/2014 6:52:00 AM - Seeking Alpha

Pluristem to Release Trial Results - Analyst Blog
1/7/2014 1:20:01 PM - Zacks.com

Pluristem's Positive Data Could Open Massive Muscle Injury Market
1/6/2014 7:17:00 PM - Seeking Alpha

Pluristem Touches 52-Week High - Analyst Blog
1/3/2014 2:34:01 PM - Zacks.com

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Diostech
12/17/2013 9:17:53 AM - MT Newswires

Sector Update: Healthcare
12/17/2013 9:17:02 AM - MT Newswires

Sector Update: Healthcare Shares Higher Pre-Market; Pluristem up 3.5% on Study Results
11/4/2013 9:54:42 AM - MT Newswires

Sector Update: Healthcare
11/4/2013 9:52:59 AM - MT Newswires

Pluristem's Promising GvHD Indication Pits It Against Osiris
10/7/2013 5:52:00 PM - Seeking Alpha

Pipeline Progress at Pluristem - Analyst Blog
10/3/2013 2:30:01 PM - Zacks.com